Eagle Pharmaceuticals shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.5k | 867 | 5.23 |
| 2023-09-30 | $14k | 867 | 15.77 |
| 2023-06-30 | $17k | 867 | 19.44 |
| 2023-03-31 | $25k | 867 | 28.37 |
| 2022-12-31 | $29k | 867 | 33.64 |
| 2022-09-30 | $22k | 867 | 25.37 |
| 2022-06-30 | $38k | 867 | 43.83 |
| 2022-03-31 | $43k | 867 | 49.60 |
| 2021-12-31 | $44k | 867 | 50.75 |
| 2021-09-30 | $48k | 867 | 55.36 |
| 2021-06-30 | $37k | 867 | 42.68 |
| 2021-03-31 | $36k | 867 | 41.52 |
| 2020-12-31 | $40k | 867 | 46.14 |
| 2020-09-30 | $37k | 867 | 42.68 |
| 2020-06-30 | $42k | 867 | 48.44 |
| 2020-03-31 | $40k | 867 | 46.14 |
| 2019-12-31 | $52k | 867 | 59.98 |
| 2019-09-30 | $49k | 867 | 56.52 |
| 2019-06-30 | $48k | 867 | 55.36 |
| 2019-03-31 | $44k | 867 | 50.75 |
| 2018-12-31 | $35k | 867 | 40.37 |
| 2018-09-30 | $60k | 867 | 69.20 |
| 2018-06-30 | $66k | 867 | 76.12 |
| 2018-03-31 | $39k | 747 | 52.21 |
| 2017-12-31 | $40k | 747 | 53.55 |
| 2017-09-30 | $40k | 747 | 53.55 |
| 2017-06-30 | $59k | 747 | 78.98 |
| 2017-03-31 | $55k | 662 | 83.08 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors